BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 23884775)

  • 21. Impact of Surgical Resection of the Primary Tumor on Overall Survival in Patients With Metastatic Pheochromocytoma or Sympathetic Paraganglioma.
    Roman-Gonzalez A; Zhou S; Ayala-Ramirez M; Shen C; Waguespack SG; Habra MA; Karam JA; Perrier N; Wood CG; Jimenez C
    Ann Surg; 2018 Jul; 268(1):172-178. PubMed ID: 28257320
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Malignant pheochromocytoma and paraganglioma: a population level analysis of long-term survival over two decades.
    Goffredo P; Sosa JA; Roman SA
    J Surg Oncol; 2013 May; 107(6):659-64. PubMed ID: 23233320
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Malignant pheochromocytoma in a population-based study: survival and clinical results.
    Wängberg B; Muth A; Khorram-Manesh A; Jansson S; Nilsson O; Forssell-Aronsson E; Tisell L; Ahlman H
    Ann N Y Acad Sci; 2006 Aug; 1073():512-6. PubMed ID: 17102119
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interferon-alpha Treatment for Disease Control in Metastatic Pheochromocytoma/Paraganglioma Patients.
    Hadoux J; Terroir M; Leboulleux S; Deschamps F; Al Ghuzlan A; Hescot S; Tselikas L; Borget I; Caramella C; Déandréis D; Goere D; De Baere T; Schlumberger M; Baudin E
    Horm Cancer; 2017 Dec; 8(5-6):330-337. PubMed ID: 28748315
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Survival of patients with metastatic malignant pheochromocytoma and efficacy of combined cyclophosphamide, vincristine, and dacarbazine chemotherapy.
    Nomura K; Kimura H; Shimizu S; Kodama H; Okamoto T; Obara T; Takano K
    J Clin Endocrinol Metab; 2009 Aug; 94(8):2850-6. PubMed ID: 19470630
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical and pathological data of 10 malignant pheochromocytomas: long-term follow up in a single institute.
    Huang KH; Chung SD; Chen SC; Chueh SC; Pu YS; Lai MK; Lin WC
    Int J Urol; 2007 Mar; 14(3):181-5. PubMed ID: 17430251
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pheochromocytoma and paraganglioma in children: a review of medical and surgical management at a tertiary care center.
    Pham TH; Moir C; Thompson GB; Zarroug AE; Hamner CE; Farley D; van Heerden J; Lteif AN; Young WF
    Pediatrics; 2006 Sep; 118(3):1109-17. PubMed ID: 16951005
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term prognosis of patients with pediatric pheochromocytoma.
    Bausch B; Wellner U; Bausch D; Schiavi F; Barontini M; Sanso G; Walz MK; Peczkowska M; Weryha G; Dall'igna P; Cecchetto G; Bisogno G; Moeller LC; Bockenhauer D; Patocs A; Rácz K; Zabolotnyi D; Yaremchuk S; Dzivite-Krisane I; Castinetti F; Taieb D; Malinoc A; von Dobschuetz E; Roessler J; Schmid KW; Opocher G; Eng C; Neumann HP
    Endocr Relat Cancer; 2014 Feb; 21(1):17-25. PubMed ID: 24169644
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Surgical Treatment of Malignant Pheochromocytoma and Paraganglioma: Retrospective Case Series.
    Strajina V; Dy BM; Farley DR; Richards ML; McKenzie TJ; Bible KC; Que FG; Nagorney DM; Young WF; Thompson GB
    Ann Surg Oncol; 2017 Jun; 24(6):1546-1550. PubMed ID: 28058556
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recurrence-Free Survival Analysis in Locally Advanced Pheochromocytoma: First Appraisal.
    Moog S; Castinetti F; DoCao C; Amar L; Hadoux J; Lussey-Lepoutre C; Borson-Chazot F; Vezzosi D; Drui D; Laboureau S; Raffin Sanson ML; Lamartina L; Pierre P; Batisse Ligner M; Hescot S; Al Ghuzlan A; Renaudin K; Libé R; Laroche S; Deniziaut G; Gimenez-Roqueplo AP; Jannin A; Leboulleux S; Guerin C; Faron M; Baudin E
    J Clin Endocrinol Metab; 2021 Aug; 106(9):2726-2737. PubMed ID: 33782697
    [TBL] [Abstract][Full Text] [Related]  

  • 31. KI-67 AND hTERT expression can aid in the distinction between malignant and benign pheochromocytoma and paraganglioma.
    Elder EE; Xu D; Höög A; Enberg U; Hou M; Pisa P; Gruber A; Larsson C; Bäckdahl M
    Mod Pathol; 2003 Mar; 16(3):246-55. PubMed ID: 12640105
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Pheochromocytoma and sympathetic paragangliomas].
    Zollinger R; Hedinger C
    Schweiz Med Wochenschr; 1983 Jul; 113(30):1057-65. PubMed ID: 6623024
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Radiolabeled DOTATOC in patients with advanced paraganglioma and pheochromocytoma.
    Forrer F; Riedweg I; Maecke HR; Mueller-Brand J
    Q J Nucl Med Mol Imaging; 2008 Dec; 52(4):334-40. PubMed ID: 18480742
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of adrenal and extraadrenal pheochromocytomas.
    Pommier RF; Vetto JT; Billingsly K; Woltering EA; Brennan MF
    Surgery; 1993 Dec; 114(6):1160-5; discussion 1165-6. PubMed ID: 8256223
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Year of diagnosis, features at presentation, and risk of recurrence in patients with pheochromocytoma or secreting paraganglioma.
    Amar L; Servais A; Gimenez-Roqueplo AP; Zinzindohoue F; Chatellier G; Plouin PF
    J Clin Endocrinol Metab; 2005 Apr; 90(4):2110-6. PubMed ID: 15644401
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nonsporadic cases and unusual morphological features in pheochromocytoma and paraganglioma.
    Lamovec J; Frković-Grazio S; Bracko M
    Arch Pathol Lab Med; 1998 Jan; 122(1):63-8. PubMed ID: 9448019
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High-dose 131I-metaiodobenzylguanidine therapy for 12 patients with malignant pheochromocytoma.
    Rose B; Matthay KK; Price D; Huberty J; Klencke B; Norton JA; Fitzgerald PA
    Cancer; 2003 Jul; 98(2):239-48. PubMed ID: 12872341
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Outcomes of patients with metastatic phaeochromocytoma and paraganglioma: A systematic review and meta-analysis.
    Hamidi O; Young WF; Gruber L; Smestad J; Yan Q; Ponce OJ; Prokop L; Murad MH; Bancos I
    Clin Endocrinol (Oxf); 2017 Nov; 87(5):440-450. PubMed ID: 28746746
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combination chemotherapy with cyclophosphamide, vincristine, and dacarbazine in patients with malignant pheochromocytoma and paraganglioma.
    Tanabe A; Naruse M; Nomura K; Tsuiki M; Tsumagari A; Ichihara A
    Horm Cancer; 2013 Apr; 4(2):103-10. PubMed ID: 23361939
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pheochromocytoma in children.
    Ciftci AO; Tanyel FC; Senocak ME; Büyükpamukçu N
    J Pediatr Surg; 2001 Mar; 36(3):447-52. PubMed ID: 11226993
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.